Hyperglycemia-Induced Reactive Oxygen Species Toxicity to Endothelial Cells Is Dependent on Paracrine Mediators

OBJECTIVE—This study determined the effects of high glucose exposure and cytokine treatment on generation of reactive oxygen species (ROS) and activation of inflammatory and apoptotic pathways in human retinal endothelial cells (HRECs). RESEARCH DESIGN AND METHODS—Glucose consumption of HRECs, human retinal pigment epithelial cells (HRPEs), and human Müller cells (HMCs) under elevated glucose conditions was measured and compared with cytokine treatment. Production of ROS in HRECs was examined using 5-(and-6)-chloromethyl-2′,7′-dichlorodihydrofluorescein diacetate (CM-H2DCFDA), spin-trap electron paramagnetic resonance, and MitoTracker Red staining after high glucose and cytokine treatment. The activation of different signaling cascades, including the mitogen-activated protein kinase pathways, tyrosine phosphorylation pathways, and apoptosis by high glucose and cytokines in HRECs, was determined. RESULTS—HRECs, in contrast to HRPEs and HMCs, did not increase glucose consumption in response to increasing glucose concentrations. Exposure of HRECs to 25 mmol/l glucose did not stimulate endogenous ROS production, activation of nuclear factor-κB (NF-κB), extracellular signal–related kinase (ERK), p38 and Jun NH2-terminal kinase (JNK), tyrosine phosphorylation, interleukin (IL)-1β, or tumor necrosis factor-α (TNF-α) production and only slightly affected apoptotic cell death pathways compared with normal glucose (5 mmol/l). In marked contrast, exposure of HRECs to proinflammatory cytokines IL-1β or TNF-α increased glucose consumption, mitochondrial superoxide production, ERK and JNK phosphorylation, tyrosine phosphorylation, NF-κB activation, and caspase activation. CONCLUSIONS—Our in vitro results indicate that HRECs respond to cytokines rather than high glucose, suggesting that in vivo diabetes–related endothelial injury in the retina may be due to glucose-induced cytokine release by other retinal cells and not a direct effect of high glucose.

[1]  F. DeLeo,et al.  Role of NF‐κB in transcriptional regulation of the phagocyte NADPH oxidase by tumor necrosis factor‐α , 2007 .

[2]  T. Kern,et al.  Oxidative damage in the retinal mitochondria of diabetic mice: possible protection by superoxide dismutase. , 2007, Investigative ophthalmology & visual science.

[3]  Yau-Huei Wei,et al.  Oxidative Stress, Mitochondrial DNA Mutation, and Apoptosis in Aging , 2007, Experimental biology and medicine.

[4]  F. Mascarelli,et al.  Placental growth factor-1 and epithelial haemato–retinal barrier breakdown: potential implication in the pathogenesis of diabetic retinopathy , 2007, Diabetologia.

[5]  S. Mohr,et al.  Inhibition of Caspase-1/Interleukin-1β Signaling Prevents Degeneration of Retinal Capillaries in Diabetes and Galactosemia , 2007, Diabetes.

[6]  E. Araki,et al.  Impact of mitochondrial ROS production in the pathogenesis of diabetes mellitus and its complications. , 2006, Antioxidants & redox signaling.

[7]  S. Sizmaz,et al.  Determination of vitreous interleukin-1 (IL-1) and tumour necrosis factor (TNF) levels in proliferative diabetic retinopathy , 2006, Eye.

[8]  D. Jump,et al.  Anti-inflammatory effect of docosahexaenoic acid on cytokine-induced adhesion molecule expression in human retinal vascular endothelial cells. , 2005, Investigative ophthalmology & visual science.

[9]  M. Bartoli,et al.  Vascular endothelial growth factor and diabetic retinopathy: role of oxidative stress. , 2005, Current drug targets.

[10]  T. Gardner,et al.  Minocycline reduces proinflammatory cytokine expression, microglial activation, and caspase-3 activation in a rodent model of diabetic retinopathy. , 2005, Diabetes.

[11]  R. Kowluru,et al.  Role of interleukin-1beta in the development of retinopathy in rats: effect of antioxidants. , 2004, Investigative ophthalmology & visual science.

[12]  Sibel Ülker,et al.  Antioxidant vitamins C and E ameliorate hyperglycaemia‐induced oxidative stress in coronary endothelial cells , 2004, Diabetes, obesity & metabolism.

[13]  Yunpeng Du,et al.  Interaction between NO and COX pathways in retinal cells exposed to elevated glucose and retina of diabetic rats. , 2004, American journal of physiology. Regulatory, integrative and comparative physiology.

[14]  R. Kowluru,et al.  Role of interleukin-1β in the pathogenesis of diabetic retinopathy , 2004, British Journal of Ophthalmology.

[15]  M. Simionescu,et al.  Aspirin rectifies calcium homeostasis, decreases reactive oxygen species, and increases NO production in high glucose-exposed human endothelial cells. , 2004, Journal of diabetes and its complications.

[16]  S. Mohr,et al.  Nuclear translocation of glyceraldehyde-3-phosphate dehydrogenase: a role in high glucose-induced apoptosis in retinal Müller cells. , 2004 .

[17]  S. Mohr Potential new strategies to prevent the development of diabetic retinopathy , 2004, Expert opinion on investigational drugs.

[18]  M. Grant,et al.  Dyslipidemia, but not hyperglycemia, induces inflammatory adhesion molecules in human retinal vascular endothelial cells. , 2003, Investigative ophthalmology & visual science.

[19]  S. Catalano,et al.  Oxidative stress in diabetes-induced endothelial dysfunction involvement of nitric oxide and protein kinase C. , 2003, Free radical biology & medicine.

[20]  L. Olson,et al.  Glucose-induced activation of glucose uptake in cells from the inner and outer blood-retinal barrier. , 2002, Investigative ophthalmology & visual science.

[21]  S. Mohr,et al.  Caspase activation in retinas of diabetic and galactosemic mice and diabetic patients. , 2002, Diabetes.

[22]  Mark A. Smith,et al.  Diabetes‐induced nitrative stress in the retina, and correction by aminoguanidine , 2002, Journal of neurochemistry.

[23]  Sten Orrenius,et al.  Cytochrome c release from mitochondria proceeds by a two-step process , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[24]  T. Bensaoula,et al.  Biochemical and ultrastructural studies in the neural retina and retinal pigment epithelium of STZ-diabetic rats: effect of captopril. , 2001, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[25]  P. Krammer,et al.  FLICE-Inhibitory Proteins: Regulators of Death Receptor-Mediated Apoptosis , 2001, Molecular and Cellular Biology.

[26]  D. Sorescu,et al.  Novel gp91phox Homologues in Vascular Smooth Muscle Cells: nox1 Mediates Angiotensin II-Induced Superoxide Formation and Redox-Sensitive Signaling Pathways , 2001, Circulation research.

[27]  H. Utsumi,et al.  High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C--dependent activation of NAD(P)H oxidase in cultured vascular cells. , 2000, Diabetes.

[28]  Y. Kaneda,et al.  Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage , 2000, Nature.

[29]  Hollifield,et al.  Evidence for control of tumour necrosis factor‐alpha (TNF‐α) activity by TNF receptors in patients with proliferative diabetic retinopathy , 1999, Clinical and experimental immunology.

[30]  J. Handa,et al.  Increase in the advanced glycation end product pentosidine in Bruch's membrane with age. , 1999, Investigative ophthalmology & visual science.

[31]  G. King,et al.  Protein kinase C activation and the development of diabetic complications. , 1998, Diabetes.

[32]  J. Williamson,et al.  Vascular dysfunction induced by elevated glucose levels in rats is mediated by vascular endothelial growth factor. , 1997, The Journal of clinical investigation.

[33]  A. Mantovani,et al.  Cytokine regulation of endothelial cell function: from molecular level to the bedside. , 1997, Immunology today.

[34]  C. Distler,et al.  Glia Cells of the Monkey Retina—II. Müller Cells , 1996, Vision Research.

[35]  M. Lorenzi,et al.  Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy. , 1996, The Journal of clinical investigation.

[36]  W. Fiers,et al.  Direct evidence for tumor necrosis factor-induced mitochondrial reactive oxygen intermediates and their involvement in cytotoxicity. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[37]  M. Brownlee Glycation and Diabetic Complications , 1994, Diabetes.

[38]  B. Glasgow,et al.  GLUT1 glucose transporter expression in the diabetic and nondiabetic human eye. , 1994, Investigative ophthalmology & visual science.

[39]  J. Forrester,et al.  Regulation of glucose transporter (GLUT 3) and aldose reductase mRNA in bovine retinal endothelial cells and retinal pericytes in high glucose and high galactose culture , 1993, Diabetologia.

[40]  J. Vilček,et al.  Cytokine regulation of interleukin-6 gene expression in astrocytes involves activation of an NF-κ B-like nuclear protein , 1992, Journal of Neuroimmunology.

[41]  J. Baynes Role of Oxidative Stress in Development of Complications in Diabetes , 1991, Diabetes.

[42]  P. Campochiaro,et al.  Aldose Reductase Expression in Human Diabetic Retina and Retinal Pigment Epithelium , 1988, Diabetes.

[43]  R. A. Field,et al.  DIABETIC RETINOPATHY AND RHEUMATOID ARTHRITIS. , 1964, Lancet.

[44]  Chowne CHARING-CROSS HOSPITAL.: ABSTRACT OF THE INTRODUCTORY LECTURE , 1843 .

[45]  R. Kowluru,et al.  Role of interleukin-1beta in the pathogenesis of diabetic retinopathy. , 2004, The British journal of ophthalmology.

[46]  A. Sevinç,et al.  Comparison of serum NO, TNF-alpha, IL-1beta, sIL-2R, IL-6 and IL-8 levels with grades of retinopathy in patients with diabetes mellitus. , 2002, Eye.

[47]  G. Lutty,et al.  Increased NADH oxidase activity in the retina of the BBZ/Wor diabetic rat. , 1998, Free radical biology & medicine.

[48]  M. Brownlee Lilly Lecture 1993. Glycation and diabetic complications. , 1994, Diabetes.

[49]  D. Lefer,et al.  Endothelial and Myocardial Cell Protection by a Cysteine‐Containing Nitric Oxide Donor After Myocardial Ischemia and Reperfusion , 1993, Journal of cardiovascular pharmacology.